ES2090802T3 - Procedimiento para la obtencion de pellets de un derivado de efedrina. - Google Patents

Procedimiento para la obtencion de pellets de un derivado de efedrina.

Info

Publication number
ES2090802T3
ES2090802T3 ES93114539T ES93114539T ES2090802T3 ES 2090802 T3 ES2090802 T3 ES 2090802T3 ES 93114539 T ES93114539 T ES 93114539T ES 93114539 T ES93114539 T ES 93114539T ES 2090802 T3 ES2090802 T3 ES 2090802T3
Authority
ES
Spain
Prior art keywords
pellets
weight
ephedrine derivative
ephedrine
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93114539T
Other languages
English (en)
Inventor
Thomas Dr Moest
Uwe Dr Loeffler
Hans Dr Waiblinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nordmark Arzneimittel GmbH and Co KG
Original Assignee
Nordmark Arzneimittel GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Arzneimittel GmbH and Co KG filed Critical Nordmark Arzneimittel GmbH and Co KG
Application granted granted Critical
Publication of ES2090802T3 publication Critical patent/ES2090802T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA ELABORACION DE PELLETS CON ESTRUCTURA ESFERICA ESTAMPADA, CON UN TAMAÑO DE GRANO EN LA ZONA DE 0,1 HASTA 4 MM Y UNA DENSIDAD A GRANEL SOBRE 0,5 G/CM3, QUE SE COMPONE DE 90 HASTA 100% EN PESO DE UN DERIVADO DE EFEDRINA Y DEL 0 HASTA EL 10% EN PESO DE UN MEDIO AUXILIAR GALENICO. EL DERIVADO DE EFEDRINA COMO POLVO CON UN TAMAÑO DE GRANO MEDIO DESDE 0,5 HASTA 50 MICRAS ESTA SUSPENDIDO A UNA TEMPERATURA DE 0 HASTA 90 CON AGUA QUE TIENEN UN PUNTO DE EBULLICION ENTRE 60 Y 160 SE ADICIONA CON GRAN AGITACION DE 5 A 60% EN PESO CON RESPECTO AL DERIVADO EFEDRINA, DE UN LIQUIDO DE AGLOMERACION SE DEJA ENFRIAR ALREDEDOR DE 5 HASTA 40 DESDE -5 HASTA 25 REVIAMENTE. LA VELOCIDAD DE AGITACION DESPUES DE LA AGLOMERACION DE LAS PARTICULAS DE POLVO SE AJUSTA A UN VALOR NECESARIO PARA EL TAMAÑO DE PELLETS DESEADO, LOS PELLETS GENERADOS SE SEPARAN Y SE SECAN. LA INVENCION SE REFIERE TAMBIEN A UN MEDICAMENTO, QUE CONTIENE PELLETS COMO SUSTANCIA ACTIVA DE ESTE TIPO EVENTUALMENTE RETARDADA.
ES93114539T 1992-09-21 1993-09-10 Procedimiento para la obtencion de pellets de un derivado de efedrina. Expired - Lifetime ES2090802T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4231493A DE4231493A1 (de) 1992-09-21 1992-09-21 Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat

Publications (1)

Publication Number Publication Date
ES2090802T3 true ES2090802T3 (es) 1996-10-16

Family

ID=6468417

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93114539T Expired - Lifetime ES2090802T3 (es) 1992-09-21 1993-09-10 Procedimiento para la obtencion de pellets de un derivado de efedrina.

Country Status (10)

Country Link
US (1) US5453280A (es)
EP (1) EP0590382B1 (es)
JP (1) JP3512834B2 (es)
AT (1) ATE140624T1 (es)
CA (1) CA2105002C (es)
DE (2) DE4231493A1 (es)
DK (1) DK0590382T3 (es)
ES (1) ES2090802T3 (es)
GR (1) GR3020622T3 (es)
MX (1) MX9305539A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683720A (en) * 1994-10-28 1997-11-04 Fuisz Technologies Ltd. Liquiflash particles and method of making same
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
DE19629032A1 (de) * 1996-07-18 1998-01-22 Knoll Ag Ephedringranulat mit hohem Wirkstoffgehalt
JP3447042B2 (ja) 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
DE10309473A1 (de) * 2003-03-05 2004-09-23 Nordmark Arzneimittel Gmbh & Co. Kg Feste, exakt dosierbare pharmazeutische Darreichungsformen zur Einzelausgabe aus Dosiervorrichtungen
US20050106310A1 (en) * 2003-07-02 2005-05-19 Green John H. Designed particle agglomeration
CN108515642A (zh) * 2018-04-02 2018-09-11 王慧丽 一种废旧塑料回收利用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5439346B2 (es) * 1971-09-27 1979-11-27
US4205060A (en) * 1978-12-20 1980-05-27 Pennwalt Corporation Microcapsules containing medicament-polymer salt having a water-insoluble polymer sheath, their production and their use
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
DE59105613D1 (de) * 1990-08-24 1995-07-06 Spirig Ag Verfahren zur Herstellung von Pellets.

Also Published As

Publication number Publication date
ATE140624T1 (de) 1996-08-15
JP3512834B2 (ja) 2004-03-31
DE4231493A1 (de) 1994-03-24
DK0590382T3 (da) 1996-08-26
CA2105002C (en) 2003-12-09
CA2105002A1 (en) 1994-03-22
DE59303308D1 (de) 1996-08-29
MX9305539A (es) 1994-03-31
US5453280A (en) 1995-09-26
JPH06192074A (ja) 1994-07-12
GR3020622T3 (en) 1996-10-31
EP0590382A1 (de) 1994-04-06
EP0590382B1 (de) 1996-07-24

Similar Documents

Publication Publication Date Title
AU650683B2 (en) Melt granulating method for drug formulation
EP0234078A1 (en) Mono-core type microcapsules and process for producing them
ES2090802T3 (es) Procedimiento para la obtencion de pellets de un derivado de efedrina.
KR950700049A (ko) 피부의 그리스성(greasiness) 조절제(AGENT FOR REGULATING THE GREASINESS OF THE SKIN)
KR910018069A (ko) 입상물 및 그의 제조방법
JPS5624429A (en) Preparation of porous spherical particle of cellulose
WO2001047560A2 (en) Particulate vitamin composition
Hildgen et al. A new gradient matrix: formulation and characterization
Peh et al. Development and in vitro evaluation of a novel multiparticulate matrix controlled release formulation of theophylline
ES2034805T3 (es) Procedimiento para la obtencion de pellets de derivados de xantina.
NO874311D0 (no) Fremgangsmaate for fremstilling av et bindemiddelfritt celiprololhydroklorid-granulat som kan tabletteres.
JP4859185B2 (ja) ゲル化剤、その製造方法およびそれを用いた固化・分離方法
US3689661A (en) Reversible agglomeration of powders for aerial dissemination
SE7700665L (sv) Forfarande for framstellning av en lekemedelskomposition
Das et al. Optimization of controlled drug release through micropelletization
JPS61238336A (ja) 徐放性被覆物の製造法
JPS57171405A (en) Solid defoaming agent and preparation thereof
JPS55153714A (en) Thiamine disulfide pharmaceutical preparation with little bitter taste and its preparation
JPH0347523A (ja) 固体粒子の被覆方法および被覆物

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 590382

Country of ref document: ES

FG2A Definitive protection

Ref document number: 590382

Country of ref document: ES